118 related articles for article (PubMed ID: 11110415)
1. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration.
Anwer K; Kao G; Proctor B; Anscombe I; Florack V; Earls R; Wilson E; McCreery T; Unger E; Rolland A; Sullivan SM
Gene Ther; 2000 Nov; 7(21):1833-9. PubMed ID: 11110415
[TBL] [Abstract][Full Text] [Related]
2. Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions.
Anwer K; Kao G; Proctor B; Rolland A; Sullivan S
J Drug Target; 2000; 8(2):125-35. PubMed ID: 10852344
[TBL] [Abstract][Full Text] [Related]
3. Cationic lipid-based delivery system for systemic cancer gene therapy.
Anwer K; Meaney C; Kao G; Hussain N; Shelvin R; Earls RM; Leonard P; Quezada A; Rolland AP; Sullivan SM
Cancer Gene Ther; 2000 Aug; 7(8):1156-64. PubMed ID: 10975676
[TBL] [Abstract][Full Text] [Related]
4. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
5. Intramuscular electroporation delivery of IFN-alpha gene therapy for inhibition of tumor growth located at a distant site.
Li S; Zhang X; Xia X; Zhou L; Breau R; Suen J; Hanna E
Gene Ther; 2001 Mar; 8(5):400-7. PubMed ID: 11313817
[TBL] [Abstract][Full Text] [Related]
6. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration.
Liu F; Qi H; Huang L; Liu D
Gene Ther; 1997 Jun; 4(6):517-23. PubMed ID: 9231067
[TBL] [Abstract][Full Text] [Related]
7. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
Wu Q; Mahendran R; Esuvaranathan K
Clin Cancer Res; 2003 Oct; 9(12):4522-8. PubMed ID: 14555526
[TBL] [Abstract][Full Text] [Related]
8. Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site.
Hanna E; Zhang X; Woodlis J; Breau R; Suen J; Li S
Cancer Gene Ther; 2001 Mar; 8(3):151-7. PubMed ID: 11332985
[TBL] [Abstract][Full Text] [Related]
9. Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure.
Suzuki R; Namai E; Oda Y; Nishiie N; Otake S; Koshima R; Hirata K; Taira Y; Utoguchi N; Negishi Y; Nakagawa S; Maruyama K
J Control Release; 2010 Mar; 142(2):245-50. PubMed ID: 19883708
[TBL] [Abstract][Full Text] [Related]
10. Combination surgery and nonviral interleukin 2 gene therapy for head and neck cancer.
Li D; Jiang W; Bishop JS; Ralston R; O'Malley BW
Clin Cancer Res; 1999 Jun; 5(6):1551-6. PubMed ID: 10389944
[TBL] [Abstract][Full Text] [Related]
11. [Combination therapy of experimental murine hepatoma with mIL-12 gene and MHC I gene mediated by liposome].
Wang KM; Xia AD; Chen SS
Ai Zheng; 2002 Oct; 21(10):1041-6. PubMed ID: 12508639
[TBL] [Abstract][Full Text] [Related]
12. Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA.
Clark PR; Stopeck AT; Ferrari M; Parker SE; Hersh EM
Cancer Gene Ther; 2000 Jun; 7(6):853-60. PubMed ID: 10880015
[TBL] [Abstract][Full Text] [Related]
13. Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy.
Eslahi NK; Muller S; Nguyen L; Wilson E; Thull N; Rolland A; Pericle F
Cancer Gene Ther; 2001 Jan; 8(1):55-62. PubMed ID: 11219494
[TBL] [Abstract][Full Text] [Related]
14. Effective transfer of interleukin-12 gene to solid tumors using a novel gene delivery system, poly [D,L-2,4-diaminobutyric acid].
Iwashita Y; Ogawa T; Goto S; Nakanishi M; Goto T; Kitano S
Cancer Gene Ther; 2004 Feb; 11(2):103-8. PubMed ID: 14671674
[TBL] [Abstract][Full Text] [Related]
15. Combined IL-2 and IL-12 gene therapy for murine head and neck squamous cell carcinoma.
Liu S; Yang H; Liang C
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):323-6. PubMed ID: 12408755
[TBL] [Abstract][Full Text] [Related]
16. Direct transfer of IL-12 gene into growing Renca tumors.
Budryk M; Wilczyńska U; Szary J; Szala S
Acta Biochim Pol; 2000; 47(2):385-91. PubMed ID: 11051203
[TBL] [Abstract][Full Text] [Related]
17. Treatment of SCCVII tumors with systemic chemotherapy and Interleukin-12 gene therapy combination.
Torrero M; Li S
Methods Mol Biol; 2008; 423():339-49. PubMed ID: 18370212
[TBL] [Abstract][Full Text] [Related]
18. [Studies of mouse interleukin-2 gene therapy for head, and neck sequamous cell carcinoma using polycationic liposome-mediated transduction].
Yang H; Liu S; Liang C; Peng W
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):9-11, 30. PubMed ID: 15600166
[TBL] [Abstract][Full Text] [Related]
19. Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model.
Horiguchi Y; Larchian WA; Kaplinsky R; Fair WR; Heston WD
Gene Ther; 2000 May; 7(10):844-51. PubMed ID: 10845722
[TBL] [Abstract][Full Text] [Related]
20. Angiographically guided utero-placental gene transfer in rabbits with adenoviruses, plasmid/liposomes and plasmid/polyethyleneimine complexes.
Heikkilä A; Hiltunen MO; Turunen MP; Keski-Nisula L; Turunen AM; Räsänen H; Rissanen TT; Kosma VM; Manninen H; Heinonen S; Ylä-Herttuala S
Gene Ther; 2001 May; 8(10):784-8. PubMed ID: 11420642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
